Tevogen Bio Holdings Inc.
TVGN
$0.39
-$0.02-4.72%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -31.04M | -31.20M | -35.36M | -13.73M | -7.92M |
| Total Depreciation and Amortization | 526.90K | 601.40K | 410.60K | 403.50K | 400.90K |
| Total Amortization of Deferred Charges | 0.00 | 0.00 | 0.00 | 800.00K | 800.00K |
| Total Other Non-Cash Items | 20.76M | 20.71M | 22.68M | 530.60K | -4.89M |
| Change in Net Operating Assets | -3.44M | -3.46M | -873.10K | -5.50K | 675.40K |
| Cash from Operations | -13.20M | -13.35M | -13.14M | -12.00M | -10.93M |
| Capital Expenditure | -- | -- | -- | -- | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | 0.00 |
| Total Debt Issued | 3.40M | 4.40M | 3.00M | 1.00M | 1.35M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 6.60M | 2.50M | 2.00M | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 2.00M | 6.00M | 8.80M | 11.00M | 9.00M |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.00K | 0.00 | 0.00 | 229.30K | 301.60K |
| Cash from Financing | 11.90M | 12.90M | 13.80M | 12.23M | 10.65M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.29M | -450.20K | 657.00K | 230.60K | -275.90K |